Paiva, Bruno <br/><br/>
The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients.  [electronic resource] 

 -  Blood  Nov 2009 
 - 4369-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2009-05-221689  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Bone Marrow Cells--pathology<br/>Disease-Free Survival<br/>Female<br/>Flow Cytometry<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Immunophenotyping<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--mortality<br/>Plasma Cells--pathology<br/>Prognosis